Geneos Wealth Management’s IGC Pharma IGC Stock Holding History

Geneos Wealth Management’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$810	Hold	3,000	–	–	﹤0.01%	2442
2026 Q1	$780	Hold	3,000	–	–	﹤0.01%	2431
2025 Q4	$840	Hold	3,000	–	–	﹤0.01%	2423
2025 Q3	$1.26K	Hold	3,000	–	–	﹤0.01%	2382
2025 Q2	$930	Hold	3,000	–	–	﹤0.01%	3006
2025 Q1	$870	Hold	3,000	–	–	﹤0.01%	2963
2024 Q4	$1.02K	Hold	3,000	–	–	﹤0.01%	2764
2024 Q3	$1.29K	Hold	3,000	–	–	﹤0.01%	2390
2024 Q2	$1.29K	Hold	3,000	–	–	﹤0.01%	1951
2024 Q1	$1.2K	Hold	3,000	–	–	﹤0.01%	1984
2023 Q4	$840	Hold	3,000	–	–	﹤0.01%	2034
2023 Q3	$1.08K	Hold	3,000	–	–	﹤0.01%	2019
2023 Q2	$930	Hold	3,000	–	–	﹤0.01%	2026
2023 Q1	$1.02K	Hold	3,000	–	–	﹤0.01%	1991
2022 Q4	$960	Hold	3,000	–	–	﹤0.01%	1969
2022 Q3	$1K	Sell	3,000 -200	-6%	-$107	﹤0.01%	1936
2022 Q2	$1K	Hold	3,200	–	–	﹤0.01%	2501
2022 Q1	$3K	Hold	3,200	–	–	﹤0.01%	2465
2021 Q4	$3K	Hold	3,200	–	–	﹤0.01%	2525
2021 Q3	$4K	Hold	3,200	–	–	﹤0.01%	2508
2021 Q2	$5K	Hold	3,200	–	–	﹤0.01%	2444
2021 Q1	$5K	Hold	3,200	–	–	﹤0.01%	2649
2020 Q4	$5K	Hold	3,200	–	–	﹤0.01%	2473
2020 Q3	$3K	Hold	3,200	–	–	﹤0.01%	2316
2020 Q2	$1K	Hold	3,200	–	–	﹤0.01%	2471
2020 Q1	$1K	Hold	3,200	–	–	﹤0.01%	2378
2019 Q4	$1K	Hold	3,200	–	–	﹤0.01%	2473
2019 Q3	$3K	Hold	3,200	–	–	﹤0.01%	2230
2019 Q2	$5K	Hold	3,200	–	–	﹤0.01%	2109
2019 Q1	$6K	Buy	+3,200	New	+$7.27K	﹤0.01%	1994
2018 Q3	–	Sell	-20,000	Closed	-$9K	–	2423
2018 Q2	$9K	Buy	+20,000	New	+$11.5K	﹤0.01%	1761

Other funds holding IGC

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Lawood & Co Williamsport, Pennsylvania $148M AUM

Geneos Wealth Management's IGC Position: Q2 2026 in Review

Geneos Wealth Management held its IGC Pharma (IGC) position steady in Q2 2026 at 3,000 shares worth $810. The position accounts for ﹤0.01% of the portfolio, ranked #2442.

Geneos Wealth Management first reported a position in IGC in Q2 2018 and has held it in 31 quarters since. The position peaked at $9K in Q2 2018. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

Geneos Wealth Management held 3,000 shares of IGC Pharma worth $810 as of Q2 2026.
Geneos Wealth Management left its IGC Pharma share count unchanged in Q2 2026.
IGC Pharma made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2442 holding.
Geneos Wealth Management first reported a position in IGC Pharma in Q2 2018 and has held it in 31 quarters since.
Geneos Wealth Management's IGC Pharma position peaked at $9K in Q2 2018.
36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.